Erratum to: Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases
- Eleanor I Ager1Email author,
- Way W Chong1,
- Shu-wen Wen1 and
- Christopher Christophi1
https://doi.org/10.1186/1475-2867-10-37
© Ager et al; licensee BioMed Central Ltd. 2010
Received: 18 October 2010
Accepted: 21 October 2010
Published: 21 October 2010
The original article was published in Cancer Cell International 2010 10:19
Correction
After publication of this work [1], we noted that we inadvertently failed to properly acknowledge all of our funding agencies. The acknowledgements section has now been modified accordingly.
Notes
Declarations
Acknowledgements
This work was supported by Cancer Australia's Priority-driven Collaborative Cancer Research Scheme and is co-funded by Cancer Australia and Cure Cancer Australia Foundation. We would also like to thank the CanToo fund raisers. Dr Ager is supported by an NHMRC Post-doctoral Training Award. Ms Shu-wen Wen is supported by an Australian Rotary Health Research Fund PhD Scholarship. We would like to thank Professor Mauro Sandrin and his team from the xenotransplantation group at Austin Health (Australia), Dr Russell Hodgson and Claire Lin, for their help with CFSE and PI staining and analysis.
Authors’ Affiliations
References
- Ager E, Chong W, Wen SW, Christophi C: Targeting the antiogensin II type 2 receptor (AT2R) in colorectal liver metastases. Cancer Cell Int. 2010, 10: 19-10.1186/1475-2867-10-19.PubMed CentralView ArticlePubMedGoogle Scholar
Copyright
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
